Center for Translational Medicine and Department of LaboratoryMedicine, The Third People's Hospital of Longgang District, Shenzhen, China; Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China; Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China; Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing, China.
Inner Mongolia Key laboratory of Hypoxic Translational Medicine, Baotou Medical College, Inner Mongolia, China.
Biomed Pharmacother. 2022 Oct;154:113623. doi: 10.1016/j.biopha.2022.113623. Epub 2022 Sep 7.
5-Aza-2'-deoxycytidine (5-Aza-CdR) is a demethylating agent that has various biological effects related to DNA methylation. DNA methylation plays important roles in learning and memory. We have reported that 5-Aza-CdR improved the performance of mice in the water maze and step-down tests. Some behaviours have been well recognized to be mediated by neurogenesis in the hippocampus. The Notch signalling pathway plays a key role in adult hippocampal neurogenesis. In this study, we examined whether 5-Aza-CdR (DNA methyltransferase inhibitor) affects neurogenesis and Notch1 expression.
The learning and memory behaviour of mice was evaluated by a conditioned avoidance learning 24 h after 5-Aza-CdR treatment. The mRNA and protein expression levels of Notch1 and HES1 were measured by real-time PCR and Western blotting. The 5-bromo-2'-deoxyuridine (BrdU)-positive cells and the expression of Notch1 in the hippocampal DG were observed through laser confocal microscopy. To further clarify whether 5-Aza-CdR affects behaviour through neurogenesis, the expression level of Notch1, cell viability and cell cycle were analysed using the HT22 cell line.
The behaviour in conditioned avoidance learning was improved, while neurogenesis and the Notch1 pathway were increased in the hippocampus of mice that were injected with 5-Aza-CdR. In vitro experiments showed that 5-Aza-CdR increased the expression of the Notch1 pathway and upregulated S-phase in the cell cycle and cell viability.
Our results suggest that the effect of 5-Aza-CdR on behaviour may be related to an increase in neurogenesis with upregulation of the Notch1 pathway in the hippocampus.
5-氮杂-2′-脱氧胞苷(5-Aza-CdR)是一种去甲基化剂,具有与 DNA 甲基化相关的多种生物学效应。DNA 甲基化在学习和记忆中起着重要作用。我们曾报道过 5-Aza-CdR 可改善水迷宫和跳下测试中小鼠的表现。一些行为已被公认为受海马体神经发生的调节。Notch 信号通路在成年海马体神经发生中起着关键作用。在这项研究中,我们研究了 5-Aza-CdR(DNA 甲基转移酶抑制剂)是否会影响神经发生和 Notch1 表达。
通过在 5-Aza-CdR 处理后 24 小时进行条件回避学习,评估小鼠的学习和记忆行为。通过实时 PCR 和 Western blot 测量 Notch1 和 HES1 的 mRNA 和蛋白表达水平。通过激光共聚焦显微镜观察 BrdU 阳性细胞和海马齿状回区 Notch1 的表达。为了进一步阐明 5-Aza-CdR 是否通过神经发生影响行为,使用 HT22 细胞系分析 Notch1 的表达水平、细胞活力和细胞周期。
条件回避学习中的行为得到改善,而海马体中的神经发生和 Notch1 途径增加。体外实验表明,5-Aza-CdR 增加了 Notch1 途径的表达,并上调了细胞周期的 S 期和细胞活力。
我们的结果表明,5-Aza-CdR 对行为的影响可能与海马体中神经发生增加和 Notch1 途径上调有关。